IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental CAR-T therapy targets lupus, ITP, and myositis in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called BZE2204 for people with three autoimmune diseases: lupus, ITP, and inflammatory myopathies. The treatment uses the patient's own immune cells, modified to attack faulty immune cells that cause the disease. The main goals are to …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated May 26, 2026 08:44 UTC
-
Experimental cell therapy targets tough autoimmune conditions
Disease control Recruiting nowThis early-stage study tests a new cell therapy called QH103 in up to 6 people with relapsed or hard-to-treat autoimmune diseases like multiple sclerosis and myasthenia gravis. The therapy uses specially engineered immune cells to target and calm the overactive immune system. The…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New cell therapy takes on lupus and muscle disease in early trial
Disease control Recruiting nowThis early-stage study tests a new treatment called LUCAR-G79D for adults with lupus or inflammatory myopathies that have not responded to standard therapies. The treatment uses a patient's own immune cells, modified to target and attack disease-causing cells. The main goals are …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Phase: PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC